NightWatch: Advanced Nocturnal Seizure Detection Designed for people that need to cope with nocturnal major motor seizures. With its clinically validated multimodal technology, NightWatch ensures that caregivers receive timely alerts, minimizing seizure related risks, including body injuries, convulsive status epilepticus and SUDEP. NightWatch is trusted among families, healthcare institutions, and researchers, underscored by its successful Phase III and IV trials. The ILAE acknowledges NightWatch as one of the select devices with sufficient evidence for use by people who sleep without supervision. Our journey began with 15 years of rigorous research in collaboration with three leading Dutch epilepsy clinics. Today, NightWatch holds a dominant position in seizure detection across several European countries and is set to expand its presence to the US market. Join us in our mission. We are actively seeking partnerships with hospitals, researchers, patient organizations and strategic partners who share our vision to ensure that every individual who requires nocturnal seizure detection has access to it.